Search - tctmd.com

Displaying 241 - 249 of 249

Sort: Relevancy | Date

Presentation Cell Therapy 2013

CD-34+ Cells for Ischemic Heart Failure

Presenter: Bojan Vrtovec

January 22, 2013

Presentation TCT 2012

TCT-88: Three-year Clinical Outcomes of the First-In-Human Experience with Percutaneous Ventricular Restoration Using the Parachute Device in Patients with Ischemic Heart...

Presenter: Marco Costa

October 23, 2012

Presentation TCT 2012

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

Presenter: Martyn Thomas

October 23, 2012

News Conference News ESC 2012

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

August 29, 2012

News Conference News ESC 2012

Good Outlook for Heart Failure Patients Given Ventricular Restoration Device

Yael L. Maxwell

August 29, 2012

Presentation ACC 2012

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial

Presenter: Emerson C. Perin

March 25, 2012

News Daily News

CMR Can Accurately Diagnose Cause of Heart Failure

Caitlin E. Cox

September 16, 2011

News Daily News

CUPID: Gene Therapy Holds Promise in Heart Failure

July 12, 2011

News Conference News

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Caitlin E. Cox

April 04, 2011

Advertisement

CD-34+ Cells for Ischemic Heart Failure

TCT-88: Three-year Clinical Outcomes of the First-In-Human Experience with Percutaneous Ventricular Restoration Using the Parachute Device in Patients with Ischemic Heart...

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

Good Outlook for Heart Failure Patients Given Ventricular Restoration Device

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial

CMR Can Accurately Diagnose Cause of Heart Failure

CUPID: Gene Therapy Holds Promise in Heart Failure

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content